Edition:
United States

John Miller

Molecular Partners gets Swiss gov't payment for COVID candidate

2:01am EDT

ZURICH Molecular Partners is getting a payment in the "high single digit millions" of Swiss francs from the Swiss government to reserve doses of an early-stage drug candidate that the Zurich-area biotechnology company is developing for COVID-19.

Schindler to cut 2,000 jobs as Chinese recovery offset by global slump

Jul 24 2020

ZURICH Schindler said on Friday it will cut 2,000 jobs over two years as regions outside China reel from COVID-19 even as the Swiss elevator maker bulks up in the world's biggest lift market, which has recovered quickly from lockdowns.

WHO scientist sees regulators cooperating to speed COVID-19 vaccine approval

Jul 24 2020

Regulators that normally work within their own countries or regions will likely harmonize efforts on potential COVID-19 vaccines to speed up their approvals once they become available, WHO chief scientist Soumya Swaminathan said on Friday.

WHO scientist sees regulators cooperating to speed COVID-19 vaccine approval

Jul 24 2020

Regulators that normally work within their own countries or regions will likely harmonize efforts on potential COVID-19 vaccines to speed up their approvals once they become available, WHO chief scientist Soumya Swaminathan said on Friday.

Lonza sees no delays for COVID-19 vaccine project, citing Trump backing

Jul 24 2020

ZURICH Swiss drugmaker Lonza sees no delays for its project to make Moderna's COVID-19 vaccine candidate and has "strong support" from U.S. President Donald Trump to get the necessary manufacturing equipment, its chairman said.

Roche sales hit by lockdowns, despite COVID-19 test boost

Jul 23 2020

ZURICH A surge in demand for Roche's COVID-19 tests, as some governments even sent military jets to pick up supplies, failed to offset the hit to other parts of the healthcare company's business from the COVID-19 pandemic, it said on Thursday.

Don't expect first COVID-19 vaccinations until early 2021: WHO's Ryan

Jul 22 2020

GENEVA/ZURICH Researchers are making "good progress" in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization (WHO) expert said on Wednesday.

Don't expect first COVID-19 vaccinations until early 2021 - WHO's Ryan

Jul 22 2020

GENEVA/ZURICH Researchers are making "good progress" in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization (WHO) expert said on Wednesday.

UPDATE 2-Don't expect first COVID-19 vaccinations until early 2021 -WHO's Ryan

Jul 22 2020

GENEVA/ZURICH, July 22 Researchers are making "good progress" in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization (WHO) expert said on Wednesday.

World News